Načítá se...
Histologic transformation of lung cancer during pembrolizumab therapy: A case report
Immune checkpoint inhibitors that block the programmed death 1/programmed death ligand 1 pathways are widely used to treat advanced lung cancers. There are seldom cases of histologic transformation reported after treatment with immunotherapy. Here, we report the case of a 69‐year‐old man with stage...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2020-03-01
|
| Edice: | Thoracic Cancer |
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/1759-7714.13312 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|